Letermovir
Brand name: Prevymis
Rank #460 of 500 drugs by total cost
$16.1M
Total Cost
2,144
Total Claims
$16.1M
Total Cost
106
Prescribers
$7,487
Cost per Claim
79
Beneficiaries
2,195
30-Day Fills
$151K
Avg Cost/Provider
20
Avg Claims/Provider
About Letermovir
Letermovir (sold as Prevymis) was prescribed 2,144 times by 106 Medicare Part D providers in 2023, costing the program $16.1M. At $7,487 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology